The Experts below are selected from a list of 189 Experts worldwide ranked by ideXlab platform
Peter K Sand - One of the best experts on this subject based on the ideXlab platform.
-
twelve month durability of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence a single arm prospective study
Urology, 2021Co-Authors: Peter J Gilling, Scott Macdiarmid, Vincent Lucente, Bilal Kaaki, Sharon English, Patrick Meffan, Matthew Clark, Subhro K Sen, Peter K SandAbstract:ABSTRACT Objectives To evaluate the safety and efficacy of the eCoin® - a nickel-sized, Primary Battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after one year of treatment with the eCoin are presented. Methods A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at seven sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months post-activation, were compared to baseline values. Results Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months, 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months. Seventy percent of participants reported feeling “better”, “much better”, or “very much better” on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. Conclusions The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.
-
feasibility of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
The Journal of Urology, 2019Co-Authors: Scott Macdiarmid, David R Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J Gilling, Patrick Meffan, Matthew Clark, Peter K Sand, Subhro K SenAbstract:Purpose:We performed a clinical feasibility trial to evaluate the safety and efficacy of a fully implanted, Primary Battery powered, nickel sized and shaped neuromodulation device called the eCoin®...
Subhro K Sen - One of the best experts on this subject based on the ideXlab platform.
-
twelve month durability of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence a single arm prospective study
Urology, 2021Co-Authors: Peter J Gilling, Scott Macdiarmid, Vincent Lucente, Bilal Kaaki, Sharon English, Patrick Meffan, Matthew Clark, Subhro K Sen, Peter K SandAbstract:ABSTRACT Objectives To evaluate the safety and efficacy of the eCoin® - a nickel-sized, Primary Battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after one year of treatment with the eCoin are presented. Methods A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at seven sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months post-activation, were compared to baseline values. Results Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months, 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months. Seventy percent of participants reported feeling “better”, “much better”, or “very much better” on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. Conclusions The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.
-
feasibility of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
The Journal of Urology, 2019Co-Authors: Scott Macdiarmid, David R Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J Gilling, Patrick Meffan, Matthew Clark, Peter K Sand, Subhro K SenAbstract:Purpose:We performed a clinical feasibility trial to evaluate the safety and efficacy of a fully implanted, Primary Battery powered, nickel sized and shaped neuromodulation device called the eCoin®...
Peter J Gilling - One of the best experts on this subject based on the ideXlab platform.
-
twelve month durability of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence a single arm prospective study
Urology, 2021Co-Authors: Peter J Gilling, Scott Macdiarmid, Vincent Lucente, Bilal Kaaki, Sharon English, Patrick Meffan, Matthew Clark, Subhro K Sen, Peter K SandAbstract:ABSTRACT Objectives To evaluate the safety and efficacy of the eCoin® - a nickel-sized, Primary Battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after one year of treatment with the eCoin are presented. Methods A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at seven sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months post-activation, were compared to baseline values. Results Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months, 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months. Seventy percent of participants reported feeling “better”, “much better”, or “very much better” on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. Conclusions The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.
-
feasibility of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
The Journal of Urology, 2019Co-Authors: Scott Macdiarmid, David R Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J Gilling, Patrick Meffan, Matthew Clark, Peter K Sand, Subhro K SenAbstract:Purpose:We performed a clinical feasibility trial to evaluate the safety and efficacy of a fully implanted, Primary Battery powered, nickel sized and shaped neuromodulation device called the eCoin®...
Scott Macdiarmid - One of the best experts on this subject based on the ideXlab platform.
-
twelve month durability of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence a single arm prospective study
Urology, 2021Co-Authors: Peter J Gilling, Scott Macdiarmid, Vincent Lucente, Bilal Kaaki, Sharon English, Patrick Meffan, Matthew Clark, Subhro K Sen, Peter K SandAbstract:ABSTRACT Objectives To evaluate the safety and efficacy of the eCoin® - a nickel-sized, Primary Battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after one year of treatment with the eCoin are presented. Methods A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at seven sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months post-activation, were compared to baseline values. Results Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months, 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months. Seventy percent of participants reported feeling “better”, “much better”, or “very much better” on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. Conclusions The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.
-
feasibility of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
The Journal of Urology, 2019Co-Authors: Scott Macdiarmid, David R Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J Gilling, Patrick Meffan, Matthew Clark, Peter K Sand, Subhro K SenAbstract:Purpose:We performed a clinical feasibility trial to evaluate the safety and efficacy of a fully implanted, Primary Battery powered, nickel sized and shaped neuromodulation device called the eCoin®...
Matthew Clark - One of the best experts on this subject based on the ideXlab platform.
-
twelve month durability of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence a single arm prospective study
Urology, 2021Co-Authors: Peter J Gilling, Scott Macdiarmid, Vincent Lucente, Bilal Kaaki, Sharon English, Patrick Meffan, Matthew Clark, Subhro K Sen, Peter K SandAbstract:ABSTRACT Objectives To evaluate the safety and efficacy of the eCoin® - a nickel-sized, Primary Battery-powered, neuromodulation device for the treatment of urgency urinary incontinence which is implanted in the lower leg in a 20-minute procedure under local anesthesia. A feasibility clinical trial was conducted and the results after one year of treatment with the eCoin are presented. Methods A total of 46 participants with refractory urgency urinary incontinence were included in this prospective, single-arm, open-label study. This study was conducted at seven sites in the United States and New Zealand. Participants in this study were implanted with the eCoin in the lower leg over the tibial nerve and activated after 4 weeks. Bladder diary data and validated quality-of-life instruments, collected at 3, 6, and 12 months post-activation, were compared to baseline values. Results Responders were defined as those who had a ≥50% reduction in reported episodes of urgency urinary incontinence. At 12 months, 65% of participants were considered responders with 26% of participants achieving complete continence. The median number of urgency urinary incontinence episodes per day decreased from 4.2 at baseline to 1.7 at 12 months. Seventy percent of participants reported feeling “better”, “much better”, or “very much better” on the Likert 7-point maximum scale. One participant experienced a related serious adverse event. Conclusions The eCoin is a safe and effective treatment for urgency urinary incontinence associated with overactive bladder syndrome, with significant reduction or complete resolution of symptoms and no significant safety concerns.
-
feasibility of a fully implanted nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence
The Journal of Urology, 2019Co-Authors: Scott Macdiarmid, David R Staskin, Vincent Lucente, Bilal Kaaki, Sharon English, Peter J Gilling, Patrick Meffan, Matthew Clark, Peter K Sand, Subhro K SenAbstract:Purpose:We performed a clinical feasibility trial to evaluate the safety and efficacy of a fully implanted, Primary Battery powered, nickel sized and shaped neuromodulation device called the eCoin®...
